Back to Home Page
Back to AryoGen Products

VedAryo contains the active substance ‘vedolizumab’. Vedolizumab is a humanized  IgG1 monoclonal antibody that binds to human integrin α4β7 and it produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.

  • VedAryo

VedAryo

VedAryo

VedAryo contains the active substance ‘vedolizumab’. Vedolizumab is a humanized  IgG1 monoclonal antibody that binds to human integrin α4β7 and it produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.

VedAryo works by blocking a protein on the surface of white blood cells that cause the inflammation in ulcerative colitis, Crohn’s disease and pouchitis. This reduces the amount of inflammation.

What VedAryo is used for

VedAryo is used to treat the signs and symptoms in adults of:

  • moderately to severely active ulcerative colitis
  • moderately to severely active Crohn’s disease
  • moderately to severely active chronic pouchitis

VedAryo is available in two forms: a vial containing 300 mg of lyophilized powder for intravenous infusion and a pre-filled syringe of 108 mg for subcutaneous injection.  

 

AryoSeven

AryoSeven is produced using recombinant BHK cells, which is stored in liquid nitrogen (-185) under cell bank regulations.

More

Altebrel

Active Raw Material (API) of Altebrel with the name of Etanercept is being purified via several pre-purification and purification steps by chromatography methods for use in final formulation.

More

Zytux

Zytux™ is a biosimilar product with the generic name of Rituximab. It is a genetically engineered human-mouse chimeric monoclonal antibody produced by Chinese Hamster Ovary (CHO) cells in suspension.

More

AryoTrust

AryoTrust (Trastuzumab) is produced by hiring recombinant CHO cells as small factories for production of the therapeutical protein.

More

Stivant

Stivant is used in different types of cancers such as; metastatic cancer of colon or rectum, progressive glioblastoma, Non-Small Cell Lung Cancer, advanced or metastatic cancer of kidney, ovarian, cervical cancer and metastatic breast cancer.

More

Temziva

Temziva can be used to treat Cytokine Release Syndrome (CRS) as the main danger cause of Corona disease in adult patients with confirmed diagnosis of covid-19.

More

Arylia

Arylia contains the active substance Denosumab with a protein stnucture. Denosumab is a human monoclonal antibody (lgG2) that targets and binds with high affinity and specificity to RANKL.

More

VedAryo

Arylia contains the active substance Denosumab with a protein stnucture. Denosumab is a human monoclonal antibody (lgG2) that targets and binds with high affinity and specificity to RANKL.

More